Catalyst Wire Dossier Catalyst Wire Dossier

Vipoglanstat

· Gesynta Pharma AB
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Vipoglanstat, covering 2026-04-17 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Trial to Investigate Efficacy and Safety of Vipoglanstat in Women With Endometriosis [Phase 2]

See pricing